LLYNEUTRAL

Current Ratio

1.50x

Updated 25h ago

Sector Performance

66th percentile

LLY

1.50x

Sector Median

1.20x

Sector Avg

2.57x

📊

Deep Analysis

A current ratio of 1.50x means Eli Lilly has $1.50 in current assets (like cash and inventory) for every $1.00 in short-term liabilities, signaling a comfortable liquidity cushion.

This sits above the sector median of 1.20x and places the company at the 66th percentile among its peers, indicating stronger-than-average short-term financial health. The trend data is not available: the year-over-year change is N/A, the quarter-over-quarter change is N/A, and no historical values beyond the 1.50x figure are provided. With no trend direction to assess, the combination of an above-median level and flat historical data suggests a stable but unremarkable liquidity position, posing low near-term risk but offering no clear signal for improvement or deterioration. This neutral metric aligns with the overall NEUTRAL verdict, as it neither strengthens nor weakens the case for a bullish or bearish stance on the stock.

Frequently Asked Questions

What does the Current Ratio tell investors about LLY?

Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.

How is the Current Ratio calculated?

Current Ratio is calculated as: Current Assets / Current Liabilities.

Who are LLY's closest peers by Current Ratio?

The closest peers by Current Ratio include: SPG (0.41x), CHTR (0.40x), USB (0.40x), GEN (0.40x), DRI (0.39x).

The Formula

Current Assets / Current Liabilities

Why It Matters

Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.

Advertisement

Master LLY's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full LLY research report

Free account — no credit card

LLY

1.50x

Sector Median

1.20x

Sector Avg

2.57x

How LLY's Current Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.